Keywords: عدم پاسخگویی پایدار; Food allergy; sensitization; tolerance; desensitization; sustained unresponsiveness; remission; allergen immunotherapy; microbiota; AD; Atopic dermatitis; Breg; Regulatory B; DC; Dendritic cell; EC; Epithelial cell; FoxP3; Forkhead box P3; ILC; Innate lym
مقالات ISI عدم پاسخگویی پایدار (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عدم پاسخگویی پایدار; Food allergy; Oral tolerance; Oral immunotherapy; Sustained unresponsiveness;
Keywords: عدم پاسخگویی پایدار; Antigen-specific; Epitope; Oral food challenge; Sustained unresponsiveness; T helper 2 cell; Tolerogenic;
Keywords: عدم پاسخگویی پایدار; Oral immunotherapy; desensitization; sustained unresponsiveness; early intervention; peanut allergy; randomized clinical trial; AE; Adverse event; DBPCFC; Double-blinded, placebo-controlled food challenge; E-OIT; Early intervention oral immunotherapy; 4-S
Keywords: عدم پاسخگویی پایدار; Oral immunotherapy; food allergy; milk allergy; omalizumab; desensitization; sustained unresponsiveness; basophil activation; biomarker; regulatory T cells; AUC; Area under the curve; FoxP3; Forkhead box P3; HR; Histamine release; MOIT; Milk oral immunoth
Keywords: عدم پاسخگویی پایدار; Food allergy; Immunotherapy; Food immunotherapy; OIT; Oral immunotherapy; SLIT; Sublingual immunotherapy; EPIT; Epicutaneous immunotherapy; AE; Adverse event; AR; Allergic rhinitis; DBPC; Double-blinded placebo-controlled; DBPCFC; Double-blinded placebo-c
Keywords: عدم پاسخگویی پایدار; desensitization; food allergy; oral immunotherapy; sustained unresponsiveness; tolerance
Keywords: عدم پاسخگویی پایدار; Food allergy; Oral immunotherapy (OIT); Desensitization; Tolerance; Sustained unresponsiveness; Skin prick test (SPT); Immunoglobulin E (IgE); Omalizumab;
Keywords: عدم پاسخگویی پایدار; Allergen immunotherapy (AIT); Sublingual immunotherapy (SLIT); Epicutaneous immunotherapy (EPIT); Food allergy; Desensitization; Oral tolerance; Sustained unresponsiveness;
Keywords: عدم پاسخگویی پایدار; Egg allergy; food allergy; oral immunotherapy; desensitization; sustained unresponsiveness; immune tolerance; IgE; follow-up; AUC; Area under the curve; eOIT; Egg oral immunotherapy; IQR; Interquartile range; kUA; Kilounits of antibody; LFQ; Long-term fol
Keywords: عدم پاسخگویی پایدار; Peanut allergy; oral immunotherapy; sublingual immunotherapy; sustained unresponsiveness; basophil activation; dendritic cells; food allergy; DBPCFC; Double-blind, placebo-controlled food challenge; DC; Dendritic cell; HR; Histamine release; mDC; Myeloid
Keywords: عدم پاسخگویی پایدار; Peanut allergy; oral immunotherapy; desensitization; tolerance; sustained unresponsiveness; DOFC; Desensitization oral food challenge; FAB; Facilitated antigen binding; OFC; Oral food challenge; OIT; Oral immunotherapy; SOFC; Sustained unresponsiveness or
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
Keywords: عدم پاسخگویی پایدار; Milk allergy; oral immunotherapy; omalizumab; desensitization; sustained unresponsiveness; double-blind; placebo-controlled trial; dose-related adverse reactions; APC; Antigen-presenting cell; CMA; Cow's milk allergy; MOIT; Milk oral immunotherapy; OFC; O
Administration of a probiotic with peanut oral immunotherapy: AÂ randomized trial
Keywords: عدم پاسخگویی پایدار; Peanut allergy; oral immunotherapy; probiotic; immune-modifying adjuvant; tolerance; sustained unresponsiveness; desensitization; peanut-specific IgE; peanut-specific IgG4; AE; Adverse event; DBPCFC; Double-blind, placebo-controlled food challenge; FDA; U